News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Maciej Wieczorek, MD

Articles by Maciej Wieczorek, MD

Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, MD

Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, MD

ByMaciej Wieczorek, MD

October 27th 2025

Maciej Wieczorek, MD, discusses CPL'36, a new PDA101 inhibitor with a novel mechanism of action for treatment of schizophrenia.

Latest Updated Articles

Trending on Psychiatric Times

Whatever Happened to Psychopathology?

Who Should Avoid Halloween Tricks and Treats?

How Can Chatbots Be Made Safe for Psychiatric Patients

Yale Expertise in Pain, Trauma Techniques Help Ukrainian MDs During Month-Long Training

The “No Kings” Rallies: Tricks or Treats?

© 2025 MJH Life Sciences^®

All rights reserved.